Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab in Pediatric Ulcerative Colitis (T72)
NCT00336492Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Sep 2006
- Primary completion
- May 2009
- Modality
- Monoclonal Antibodies
- Countries
- 5
01
Overview
A Phase 3 trial of infliximab in ulcerative colitis (UC), sponsored by Janssen Pharmaceutical. Started Sep 2006; status: completed.
02
Drugs
infliximab
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00336492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00336492.